News

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...
The framework the new FDA leaders laid out on Tuesday raised small and big questions about the regulatory process, vaccine ...
A Phoenix doctor weighs in on the potential impact of FDA plans to limit COVID booster access to high-risk groups, raising ...
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...
The revised version of the vaccine, marketed as Spikevax, follows FDA guidance recommending that this year’s shots target ...
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
Almost immediately after former US president Joe Biden's office announced he had been diagnosed with an aggressive prostate ...
Dr. Peter McCullough testified Thursday at a Senate hearing on "The Corruption of Science and Federal Health Agencies: How Health Officials Downplayed and Hid Myocarditis and Other Adverse Events ...